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Abstract
Background:  Myxoid liposarcoma is the second most commonly occurring sub-type of
liposarcomas. In contrast to other soft tissue sarcomas, it is known to have a tendency to spread
toward extrapulmonary sites, such as soft tissues, retroperitoneum, and the peritoneal surface.
Bony spread, however, is not as common.
Case presentation: We report an unusual case of diffuse skeletal metastases from myxoid
liposarcoma occurring 13 years after treatment of the primary tumour in the left lower limb. The
skeletal spread of the disease was demonstrated on MRI only after other imaging modalities (plain
radiography, CT and TC99 bone scans) had failed to detect these metastases.
Conclusion: MRI is an extremely sensitive and specific screening tool in the detection of skeletal
involvement in these types of sarcomas, and therefore, should be a part of the staging process.
Background
Liposarcomas are a group of soft tissue malignancies in
which the direction of differentiation is toward fatty tis-
sue. The trunk and the lower extremities are the most
likely sites of tumour development [1,2]. Liposarcomas
are classified histologically into three grades (Table 1),
with metastases occurring according to this grade. Low-
grade lesions account for <10%, intermediate grade 10%
to 15%, and high grade > 50% [2-4]. Myxoid liposarcoma
(intermediate-grade) is the second most frequently occur-
ring subtype, accounting for one third of cases, and repre-
senting about 10% of all adult soft tissue sarcomas [5]. It
is well known the majority of soft tissue sarcomas metas-
tasise to the lungs [3,4]. MLS, in contrast, has a different
pattern of metastatic spread. It has a tendency toward
extrapulmonary sites, such as soft tissues, retroperito-
neum, peritoneal surface, and the axilla. However, bony
spread is not as common [1-3]. We report a case of MLS
associated with unusual late diffuse skeletal metastases
detected only by MR imaging.
Case presentation
A 51-year old Caucasian male presented to his local hos-
pital with a history of an enlarging painful mass in his left
thigh in 1992. A needle biopsy was in keeping with the
diagnosis of a myxoid liposarcoma, and full staging imag-
ing did not reveal any secondary lesions. A wide local exci-
sion was performed and subsequent histopathological
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examination showed a completely excised high-grade
myxoid liposarcoma. Fractions of radiotherapy (60 Gy)
were administered postoperatively. In both 1997 and
1999, local recurrences occurred, for which surgical exci-
sions with wide margins were achieved. Surgery was sup-
plemented with radiotherapy on both occasions. In 2004,
the tumour disseminated to three distant sites including
the liver, chest wall, and neck. The metastases were suc-
cessfully resected. Histopathological examination
revealed similar cellular findings do the primary tumour
(Figure 1). As the surgical margins were clear, no further
treatments were deemed necessary at that stage. In 2005,
the patient started complaining of back pain but plain spi-
nal radiographs, CT (chest, abdomen and pelvis) and a TC
99m bone scan (Figure 2) did not reveal any signs of spi-
nal disease. However, a spinal MRI (Figure 3) showed a
diffuse and widespread abnormal bone marrow signal not
detected previously. A bone marrow aspirate suggested
the diagnosis of metastatic disease. During 2006, chemo-
therapy (Doxorubicin, Ifosfamide, and Trabectedin) and
radiotherapy (fractions of 20 Gy) were administered,
resulting in good symptomatic recovery, with no disease
progression. In 2007, the patient sustained a pathological
fracture in his left proximal femur following a fall. An MRI
revealed multiple well-defined foci of abnormal signal
throughout both femora and in the right pubis and both
ischia, in addition to the fracture. He subsequently under-
went a proximal femoral replacement at our institution
with the view of achieving good pain relief and a reason-
able functional outcome. Histopathological examination
revealed extensive bone necrosis secondary to radiother-
apy, but no viable tumour cells were identified. Single
agent Trabectedin was given postoperatively. The patient
died of his disease eleven months later, 15 years after ini-
tial diagnosis.
Discussion
Our case demonstrates the possibility of diffuse bone
involvement with myxoid liposarcoma, even late in the
course of the disease. This uncommon pattern of spread
should certainly be taken into account when staging
patients and determining their prognosis. It also shows
the value of MRI in the detection of these metastases.
Other methods for assessing skeletal metastases, includ-
ing plain radiography, CT scanning and Tc 99m isotope
scanning, would appear on the evidence of this, and other
Table 1: Classification of Liposarcomas
Low Grade Intermediate Grade High Grade
Well differentiated Lipoma like Sclerosing Inflammatory Myxoid Dedifferentiated Round cell Pleomorphic
Histology slide of myxoid liposarcoma showing lipoblasts and capillaries in a predominantly myxoid stroma (H&E stain, 10×  magnifications) Figure 1
Histology slide of myxoid liposarcoma showing lipoblasts and capillaries in a predominantly myxoid stroma (H&E stain, 10× 
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cases [6-9], to be insensitive to myxoid liposarcoma.
Schwab et al. [8] have shown that even PET scans lack suf-
ficient sensitivity to detect spinal involvement in this dis-
ease and recommended the use of total spine MRI when
screening for metastases in MLS patients. Because bone
secondaries are not common in soft tissue sarcomas, skel-
etal staging would not be routinely performed in many
centres. Furthermore, relying solely on CT as a staging tool
in these cancers might result in a significant number of
metastases being missed. MRI, on the other hand, is an
extremely sensitive tool to bone marrow replacement by
abnormal tissue, as the high contrast between fat (mar-
row) and water (tumour) demonstrates metastatic lesions
at an early stage [10]. We believe that whole-body MRI
may be a more appropriate staging investigation of this
particular tumour with unique clinical features. Because
our patient was initially asymptomatic, there was no way
to detect the metastatic bone lesions and no reason to sus-
pect they were present, and this may explain the late diag-
nosis. We do not know when skeletal lesions first
occurred, as no spinal MRI was obtained between initial
diagnosis and 2005. In addition, all other surveillance
imaging investigations were negative. Ishii et al. [6] have
reported two cases of relatively early bone metastases (2
and 4 years latency) not detected by bone scans. They
attributed the normal accumulation of radiotracers to the
likely diminished metabolic bone activity. Other authors
have suggested that the myxoid stroma may prevent
labelled glucose from reaching cells in sufficient quantity
to be detected by the scanner [8].
Technetium bone scan Figure 2
Technetium bone scan. No significant uptake in the skull (a), spine and pelvis (b), and proximal femora (c).
Diffuse abnormal bone marrow signal throughout the spine Figure 3
Diffuse abnormal bone marrow signal throughout the spine. Note multiple lesions with high-signal centres on T1W, reflecting 
the myxoid/fatty nature of the deposits. (a) Sagittal T1W MR iamge of cervical and thoracic spines. (b) Sagittal T1W MR iamge 
of lumbosacral spine. (c) Transverse section T2W MR image in L3.Publish with BioMed Central    and   every 
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Conclusion
By reporting this case, we emphasise two important
points; diffuse skeletal metastases can occur late in the
course of MLS (13 years latency in this case), and MRI
appears to be more sensitive than any other imaging
modality in detecting bone marrow involvement in this
disease. It is therefore essential to consider the value of
whole-body MRI in the management of patients with
intermediate (myxoid) to high grade liposarcomas. We
recommend this be used in the initial staging process, and
whenever local recurrence/metastases are suspected.
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